Ethicon Surgifoam To Ship In Early Nov. At An Average Cost Of About $23
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Ethicon unit plans to commence shipments of its Surgifoam absorbable gelatin sponge for use as a hemostat in early November following FDA approval Sept. 30 via premarket approval application.